How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions
A new review explores the higher risk of thrombotic disease with this coronavirus, how to prevent and treat it, plus research gaps.
Michael O’Riordan
Introduction
Solid data is lacking, but an emerging body of evidence suggests that COVID-19 may predispose patients to arterial and venous thrombotic disease, and that some of the therapies under investigation may pose distinct drug-drug interactions with common antithrombotic medications.
That’s prompted a global effort to summarize what’s known to date about preventing venous thromboembolism (VTE) in patients with COVID-19 during hospitalization and back at home, as well as the ideal management of COVID-19-positive patients with a VTE diagnosis.
Fonte:
https://www.tctmd.com/news/how-covid-19-promotes-thrombosis-posing-problems-drug-drug-interactions
April 22, 2020